Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > And today we're mentioned in the Globe and Mail

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Jan 18, 2022 9:15am

169 Views

Post# 34327764

RE:RE:And today we're mentioned in the Globe and Mail

Blockbuster is synonymous with bankrupt haha. I can still see that ugly blue and yellow logo.

Stockfshr wrote: Yes. Love that the Globe reused the word "blockbuster" from Chelsea's report.
"Ms. Stellick thinks Sernova possesses "blockbuster potential to establish a new standard of care for diabetes treatment and apply its platform to other chronic diseases using several complementary technologies."